Synthesis and evaluation of novel 18 F-labeled quinazoline derivatives with low lipophilicity for tumor PET imaging

Author:

Chong Yan1,Chang Jin1,Zhao Wenwen1,He Yong1,Li Yuqiao1,Zhang Huabei1,Qi Chuanmin1ORCID

Affiliation:

1. Key Laboratory of Radiopharmaceuticals, College of Chemistry; Beijing Normal University; Beijing People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Reference25 articles.

1. Targeting the ERBB family in cancer: couples therapy;Tebbutt;Nat Rev Cancer,2013

2. Targeted therapy for non-small-cell lung cancer using EGFR-TKIs;Tan;Chin J New Drugs,2011

3. A specific inhibitor of the epidermal growth-factor receptor tyrosine kinase;Fry;Science,1994

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

5. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy;Wakeling;Cancer Res,2002

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3